3 “Strong Buy” Biotech Stocks That Recently Went Public

This year has seen more than its share of successful IPOs – and some giant flops. The extremes should have been expected, in a year with a record number of new public offerings. The second quarter was the best quarter for IPO activity in the last four years, with 62 companies raising $25 billion – and bringing in an average return of 30%. The tech and biotech sectors led the way.IPO activity has continued in the second half, but with lesser returns. Tech startups have been underperforming the general market, returning about 5% against the S&P year-to-date average of 22%. …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.